SARRECCHIA, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 11.673
EU - Europa 1.259
AS - Asia 1.179
SA - Sud America 191
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 17
OC - Oceania 5
Totale 14.451
Nazione #
US - Stati Uniti d'America 11.625
SG - Singapore 586
CN - Cina 271
IT - Italia 204
DE - Germania 157
BR - Brasile 150
UA - Ucraina 148
RU - Federazione Russa 123
FR - Francia 122
SE - Svezia 114
PL - Polonia 100
IE - Irlanda 90
VN - Vietnam 85
FI - Finlandia 82
HK - Hong Kong 70
GB - Regno Unito 57
BD - Bangladesh 38
KR - Corea 32
JP - Giappone 29
CA - Canada 22
IN - India 15
MX - Messico 14
AR - Argentina 13
CZ - Repubblica Ceca 13
BE - Belgio 11
TR - Turchia 10
EC - Ecuador 8
ID - Indonesia 8
NL - Olanda 8
ES - Italia 7
ZA - Sudafrica 7
CO - Colombia 6
AU - Australia 5
CH - Svizzera 5
CL - Cile 5
IQ - Iraq 5
AT - Austria 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
EG - Egitto 3
MA - Marocco 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PK - Pakistan 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
VI - Stati Uniti Isole Vergini 1
Totale 14.329
Città #
Woodbridge 3.207
Wilmington 2.825
Houston 2.498
Fairfield 365
Singapore 346
Ashburn 271
Chandler 268
Ann Arbor 221
San Jose 147
Seattle 138
Jacksonville 117
Cambridge 116
Beijing 100
Kraków 85
Dublin 84
New York 80
Rome 80
Hong Kong 67
Council Bluffs 65
Medford 63
Dearborn 62
Santa Clara 62
Helsinki 53
Los Angeles 48
Zhengzhou 47
The Dalles 41
Milan 35
Lawrence 30
Ho Chi Minh City 29
Boardman 28
Tokyo 24
Hanoi 23
Lauterbourg 23
São Paulo 23
Munich 22
Menlo Park 20
Chicago 18
Denver 18
San Diego 18
San Francisco 17
Buffalo 16
Phoenix 16
Moscow 15
Palo Alto 14
Redondo Beach 13
Shanghai 13
Warsaw 13
Montreal 12
Mülheim 12
Orem 12
Brussels 11
Dallas 11
London 11
Nanjing 11
Verona 11
Stockholm 9
Creede 8
Falls Church 8
Jakarta 8
Atlanta 7
Brno 7
Brooklyn 7
Columbus 7
Nuremberg 7
Amsterdam 6
Ankara 6
Belo Horizonte 6
Boston 6
Charlotte 6
Dong Ket 6
Hefei 6
Manchester 6
North Bergen 6
Olomouc 6
Rio de Janeiro 6
Schiffdorf 6
Boydton 5
Johannesburg 5
Kunming 5
Poplar 5
Redwood City 5
University Park 5
Brasília 4
Chennai 4
Colorado Springs 4
Dhaka 4
Frankfurt am Main 4
Guangzhou 4
Guayaquil 4
Madrid 4
Nanchang 4
Southport 4
Anápolis 3
Auburn Hills 3
Brescia 3
Chengdu 3
Cranston 3
Curitiba 3
Honolulu 3
Jinan 3
Totale 12.209
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 593
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 525
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 505
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 502
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 499
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 498
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. 497
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 490
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 490
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. 483
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 481
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 478
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb 477
Multidrug resistance after lamivudine therapy for chronic hepatitis B 476
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 475
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 475
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 471
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 465
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 460
Aciclovir, herpes viruses and HIV: a never-ending story 449
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance 440
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 438
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. 407
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. 406
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon 404
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen 402
Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype 399
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients 395
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 392
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 384
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 320
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 113
Evaluation of the antibody response to EBNA-1 in EBV infections | VALIDITA DELLA RICERCA DEGLI ANTICORPI ANTI EBNA-1 NELLA DIAGNOSTICA DELLE INFEZIONI DA EBV 110
Therapy and prevention of infective endocarditis 52
Totale 14.451
Categoria #
all - tutte 31.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022345 0 0 0 22 4 32 21 13 103 33 15 102
2022/2023608 54 65 54 92 41 118 35 54 51 7 25 12
2023/2024200 31 2 11 4 6 66 0 14 4 8 0 54
2024/2025795 24 170 95 44 48 30 61 34 121 61 55 52
2025/20261.401 97 57 137 156 128 53 276 127 161 97 68 44
2026/2027479 76 79 245 79 0 0 0 0 0 0 0 0
Totale 14.451